Test Name: UroVysion Bladder Cancer FISH
Cytogenetic studies reveal frequent alterations of a variety of chromosomes associated with bladder carcinoma including chromosomes 1, 3, ,5, 7, 9, 10, 17, and others. The UroVysion Bladder Cancer Kit (UroVysion Kit) is designed to detect aneuploidy for chromosomes 3, 7, 17, and loss of the 9p21 locus via fluorescence in situ hybridization (FISH) in urine specimens from persons with hematuria suspected of having bladder cancer. Results from the UroVysion Kit are intended for use, in conjunction with and not in lieu of current standard diagnostic procedures, as an aid for initial diagnosis of bladder carcinoma in patients with hematuria and subsequent monitoring for tumor recurrence in patients previously diagnosed with bladder cancer.
Voided urine mixed 2:1 (v:v) with recommended PreservCyt (Hologic) or NuCyte fixative.
Storage and Transport
Specimen should be stored and transported refrigerated with a cool pack.
Specimen Rejection Criteria
Turn Around Time (TAT): 3 - 5 Days
CPT Codes*: 88120
*The CPT codes provided with our Test Descriptions are based on AMA guidelines and are for informational purposes only. Correct CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed.